128 related articles for article (PubMed ID: 11576836)
1. First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study.
Papakostas P; Kouroussis C; Androulakis N; Samelis G; Aravantinos G; Kalbakis K; Sarra E; Souglakos J; Kakolyris S; Georgoulias V
Eur J Cancer; 2001 Oct; 37(15):1833-8. PubMed ID: 11576836
[TBL] [Abstract][Full Text] [Related]
2. Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF): a phase II trial.
Mavroudis D; Kourousis C; Androulakis N; Kalbakis K; Agelaki S; Kakolyris S; Souglakos J; Sarra E; Vardakis N; Hatzidaki D; Sarmonis G; Georgoulias V
Am J Clin Oncol; 2000 Aug; 23(4):341-4. PubMed ID: 10955859
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer.
Chevallier B; Fumoleau P; Kerbrat P; Dieras V; Roche H; Krakowski I; Azli N; Bayssas M; Lentz MA; Van Glabbeke M
J Clin Oncol; 1995 Feb; 13(2):314-22. PubMed ID: 7844592
[TBL] [Abstract][Full Text] [Related]
4. A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: report of the Clinical Screening Group of the EORTC.
Fumoleau P; Chevallier B; Kerbrat P; Krakowski Y; Misset JL; Maugard-Louboutin C; Dieras V; Azli N; Bougon N; Riva A; Roche H
Ann Oncol; 1996 Feb; 7(2):165-71. PubMed ID: 8777173
[TBL] [Abstract][Full Text] [Related]
5. A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC. European Organization for Research and Treatment of Cancer.
Dieras V; Chevallier B; Kerbrat P; Krakowski I; Roche H; Misset JL; Lentz MA; Azli N; Murawsky M; Riva A; Pouillart P; Fumoleau P
Br J Cancer; 1996 Aug; 74(4):650-6. PubMed ID: 8761385
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of docetaxel chemotherapy in patients with incurable adenocarcinoma of the esophagus.
Heath EI; Urba S; Marshall J; Piantadosi S; Forastiere AA
Invest New Drugs; 2002 Feb; 20(1):95-9. PubMed ID: 12003198
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58.
Smith RE; Anderson SJ; Brown A; Scholnik AP; Desai AM; Kardinal CG; Lembersky BC; Mamounas EP
Clin Breast Cancer; 2002 Dec; 3(5):333-40. PubMed ID: 12533263
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of single-agent docetaxel chemotherapy for non-small cell lung cancer.
Perng RP; Shih JF; Chen YM; Chou KC; Lee YC; Tsai CM
Jpn J Clin Oncol; 2000 Oct; 30(10):429-34. PubMed ID: 11185888
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas.
Jones DV; Lozano R; Hoque A; Markowitz A; Patt YZ
J Clin Oncol; 1996 Aug; 14(8):2306-10. PubMed ID: 8708721
[TBL] [Abstract][Full Text] [Related]
10. Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: a multicenter phase II study.
Androulakis N; Kourousis C; Dimopoulos MA; Samelis G; Kakolyris S; Tsavaris N; Genatas K; Aravantinos G; Papadimitriou C; Karabekios S; Stathopoulos GP; Georgoulias V
J Clin Oncol; 1999 Jun; 17(6):1779-85. PubMed ID: 10561215
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of docetaxel in patients with pancreatic cancer previously untreated with cytotoxic chemotherapy.
Lenzi R; Yalcin S; Evans DB; Abbruzzese JL
Cancer Invest; 2002; 20(4):464-72. PubMed ID: 12094541
[TBL] [Abstract][Full Text] [Related]
12. A multicentre phase II trial of cabazitaxel in patients with advanced non-small-cell lung cancer progressing after docetaxel-based chemotherapy.
Kotsakis A; Matikas A; Koinis F; Kentepozidis N; Varthalitis II; Karavassilis V; Samantas E; Katsaounis P; Dermitzaki EK; Hatzidaki D; Mavroudis D; Georgoulias V
Br J Cancer; 2016 Sep; 115(7):784-8. PubMed ID: 27607471
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293.
Einzig AI; Neuberg D; Remick SC; Karp DD; O'Dwyer PJ; Stewart JA; Benson AB
Med Oncol; 1996 Jun; 13(2):87-93. PubMed ID: 9013471
[TBL] [Abstract][Full Text] [Related]
14. A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma.
Rougier P; Adenis A; Ducreux M; de Forni M; Bonneterre J; Dembak M; Clouet P; Lebecq A; Baille P; Lefresne-Soulas F; Blanc C; Armand JP
Eur J Cancer; 2000 May; 36(8):1016-25. PubMed ID: 10885606
[TBL] [Abstract][Full Text] [Related]
15. A dose escalation study of weekly docetaxel in patients with advanced solid tumors.
Kouroussis C; Agelaki S; Mavroudis D; Souglakos J; Kakolyris S; Kalbakis K; Vardakis N; Reppa D; Hatzidaki D; Samonis G; Georgoulias V
Cancer Chemother Pharmacol; 2000; 46(6):488-92. PubMed ID: 11138462
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial.
Alexopoulos K; Kouroussis C; Androulakis N; Papadakis E; Vaslamatzis M; Kakolyris S; Samelis G; Patila E; Vossos A; Samantas E; Georgoulias V
Cancer Chemother Pharmacol; 1999; 43(3):257-62. PubMed ID: 9923557
[TBL] [Abstract][Full Text] [Related]
17. A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer.
Adachi I; Watanabe T; Takashima S; Narabayashi M; Horikoshi N; Aoyama H; Taguchi T
Br J Cancer; 1996 Jan; 73(2):210-6. PubMed ID: 8546908
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of docetaxel (Taxotere) in metastatic colorectal carcinoma.
Pazdur R; Lassere Y; Soh LT; Ajani JA; Bready B; Soo E; Sugarman S; Patt Y; Abbruzzese JL; Levin B
Ann Oncol; 1994 May; 5(5):468-70. PubMed ID: 7915537
[TBL] [Abstract][Full Text] [Related]
19. First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbine.
Kourousis C; Androulakis N; Kakolyris S; Souglakos J; Maltezakis G; Metaxaris G; Chalkiadakis G; Samonis G; Vlachonikolis J; Georgoulias V
Cancer; 1998 Nov; 83(10):2083-90. PubMed ID: 9827712
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of docetaxel with dexamethasone premedication in patients with advanced non-small cell lung cancer: the Canadian experience.
Latreille J; Gelmon KA; Hirsh V; Laberge F; Maksymiuk AW; Shepherd FA; Delorme F; BĂ©rille J
Invest New Drugs; 1998-1999; 16(3):265-70. PubMed ID: 10360607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]